Cargando…
Programming CAR T Cell Tumor Recognition: Tuned Antigen Sensing and Logic Gating
The success of chimeric antigen receptor (CAR) T cells targeting B-cell malignancies propelled the field of synthetic immunology and raised hopes to treat solid tumors in a similar fashion. Antigen escape and the paucity of tumor-restricted CAR targets are recognized challenges to fulfilling this pr...
Autores principales: | Hamieh, Mohamad, Mansilla-Soto, Jorge, Rivière, Isabelle, Sadelain, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068450/ https://www.ncbi.nlm.nih.gov/pubmed/36961206 http://dx.doi.org/10.1158/2159-8290.CD-23-0101 |
Ejemplares similares
-
S104: DIFFERENTIAL TARGET PROFILES AND EFFICACY OF ADCLEC.SYN1 AND CD33-CARS IN HUMANIZED AML MODELS
por: Haubner, Sascha, et al.
Publicado: (2023) -
How do CARs work?: Early insights from recent clinical studies targeting CD19
por: Davila, Marco L., et al.
Publicado: (2012) -
G-quadruplexes for luminescent sensing and logic gates
por: He, Hong-Zhang, et al.
Publicado: (2013) -
Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells
por: Saleh, Haidy A., et al.
Publicado: (2023) -
Driving CARs to new places: locally produced BCMA CAR T cells to treat multiple myeloma
por: Sjöstrand, Maria, et al.
Publicado: (2023)